Aventis Pasteur statement on HVTN 501 decision
Aventis Pasteur remains committed to the continued development of its ALVAC vector as a preventive AIDS vaccine. The knowledge gleaned from HIV Vaccine Trials Network (HVTN) 203 will be useful in moving future studies forward both in the U.S. and internationally. ...... There is no known correlate of protection for HIV vaccines. HVTN 501 was designed to determine possible correlates in additi...Aventis Pasteur ready to meet nation's needs for tetanus and diphtheria vaccine
Swiftwater, PA June 20, 2002 Aventis Pasteur announced today that it has produced a sufficient supply of the adult and adolescent vaccine for tetanus and diphtheria, Tetanus and Diphtheria Toxoids Adsorbed For Adult Use (Td), to meet the nation's critical care and routine booster needs. According to the June 21, 2002, issue of the U.S. Centers for Disease Control and Prevention's (CDC) Morbid...Aventis Pasteur donates approximately 75 to 90 million doses of smallpox vaccine to the U.S.
Swiftwater, PA March 29, 2002 -- Aventis Pasteur, the vaccines business of Aventis Pharma, announced today that it will donate its smallpox vaccine inventory to the U.S. governments emergency preparedness stockpiles. The inventory is estimated to be between 75 and 90 million doses with the exact amount to be confirmed by clinical studies. The vaccine comes from the companys existing stock and....CAMBRIDGE, Mass. and FRANKFURT, Germany, June 23, 2000 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) and Aventis Pharma, the pharmaceutical company of Aventis S.A. (NYSE: AVE), and today announced that they have formed a unique alliance with the signing of agreements covering the joint development and commercialization of drugs for the treatment of inflammatory diseases; joint development....PARSIPPANY, N.J., June 5, 2000 -- Aventis Pharmaceuticals announced today that .Allegra® (fexofenadine HCl) 30-mg tablets, twice daily (BID), are now available by prescription for the relief of seasonal allergic rhinitis (SAR) and chronic idiopathic urticaria (CIU) in children aged 6 to 11 years.. ."Seasonal allergies affect up to six million children in the United States," said Eli Meltzer...